Analysts think MGRM stock price could increase by 95%
Dec 28, 2024, 12:26 PM
9.58%
What does MGRM do
Monogram Orthopaedics, based in Brooklyn, New York, went public on May 18, 2023, employing 28 staff. The company develops patient-optimized orthopedic implants using 3D printing, AI, and robotics.
4 analysts think MGRM stock price will increase by 95.40%. The current median analyst target is $5.10 compared to a current stock price of $2.61. The lowest analysts target is $4.04 and the highest analyst target is $6.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
